OrganoClick AB Statistics

Total Valuation

OrganoClick AB has a market cap or net worth of SEK 293.37 million. The enterprise value is 345.64 million.

Market Cap	293.37M
Enterprise Value	345.64M

Important Dates

The last earnings date was Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

OrganoClick AB has 98.12 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	n/a
Shares Outstanding	98.12M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	36.79%
Owned by Institutions (%)	19.94%
Float	54.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.19
PB Ratio	7.97
P/TBV Ratio	22.86
P/FCF Ratio	107.82
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 102.50, with an EV/FCF ratio of 127.03.

EV / Earnings	-19.69
EV / Sales	2.59
EV / EBITDA	102.50
EV / EBIT	n/a
EV / FCF	127.03

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.03.

Current Ratio	0.73
Quick Ratio	0.32
Debt / Equity	1.03
Debt / EBITDA	14.04
Debt / FCF	17.40
Interest Coverage	-1.62

Financial Efficiency

Return on equity (ROE) is -28.95% and return on invested capital (ROIC) is -6.38%.

Return on Equity (ROE)	-28.95%
Return on Assets (ROA)	-4.09%
Return on Capital (ROIC)	-6.38%
Revenue Per Employee	3.26M
Profits Per Employee	-428,171
Employee Count	46
Asset Turnover	0.87
Inventory Turnover	2.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.47% in the last 52 weeks. The beta is 1.04, so OrganoClick AB's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-21.47%
50-Day Moving Average	2.87
200-Day Moving Average	3.18
Relative Strength Index (RSI)	61.73
Average Volume (20 Days)	159,908

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OrganoClick AB had revenue of SEK 133.71 million and -17.56 million in losses. Loss per share was -0.18.

Revenue	133.71M
Gross Profit	34.26M
Operating Income	-10.11M
Pretax Income	-15.31M
Net Income	-17.56M
EBITDA	-4.76M
EBIT	-10.11M
Loss Per Share	-0.18

Full Income Statement

Balance Sheet

The company has 4.34 million in cash and 47.36 million in debt, giving a net cash position of -43.02 million or -0.44 per share.

Cash & Cash Equivalents	4.34M
Total Debt	47.36M
Net Cash	-43.02M
Net Cash Per Share	-0.44
Equity (Book Value)	46.06M
Book Value Per Share	0.38
Working Capital	-24.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.56 million and capital expenditures -2.84 million, giving a free cash flow of 2.72 million.

Operating Cash Flow	5.56M
Capital Expenditures	-2.84M
Free Cash Flow	2.72M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 25.62%, with operating and profit margins of -7.56% and -13.13%.

Gross Margin	25.62%
Operating Margin	-7.56%
Pretax Margin	-11.45%
Profit Margin	-13.13%
EBITDA Margin	-3.56%
EBIT Margin	-7.56%
FCF Margin	2.04%

Dividends & Yields

OrganoClick AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	-0.05%
Earnings Yield	-5.99%
FCF Yield	0.93%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OrganoClick AB has an Altman Z-Score of -0.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.2
Piotroski F-Score	n/a